NASDAQ:TBPH | Operating Income | Theravance Biopharma, Inc.

Complete source-backed operating income history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$8.28M
2026-03-31-$9.48M
2025-12-31$20.01M
2025-09-30-$6.46M
2025-06-30-$2.73M
2025-03-31-$14.43M
2024-12-31-$9.2M
2024-09-30-$10.84M
2024-06-30-$15.71M
2024-03-31-$11.21M
2023-12-31-$6.24M
2023-09-30-$8.76M
2023-06-30-$16.12M
2023-03-31-$24.91M
2022-12-31-$17.43M
2022-09-30-$14.2M
2022-06-30-$23.1M
2022-03-31-$37.22M
2021-12-31-$56.17M
2021-09-30-$53.62M
2021-06-30-$64.11M
2021-03-31-$83.89M
2020-12-31-$76.36M
2020-09-30-$76.62M
2020-06-30-$72.18M
2020-03-31-$72.48M
2019-12-31-$70.57M
2019-09-30-$65.2M
2019-06-30-$42.48M
2019-03-31-$73.67M
2018-12-31-$62.62M
2018-09-30-$62.45M
2018-06-30-$48.7M
2018-03-31-$64.98M
2017-12-31-$79.18M
2017-09-30-$57M
2017-06-30-$65.12M
2017-03-31-$58.83M
2016-12-31-$57.83M
2016-09-30-$33.49M
2016-06-30-$47.5M
2016-03-31-$41.64M
2015-12-31-$55.77M
2015-09-30-$43.1M
2015-06-30-$45.29M
2015-03-31-$37.74M
2014-12-31-$65.75M
2014-09-30-$50.06M
2014-06-30-$56.71M
2014-03-31-$60.02M
2013-12-31-$44.08M
2013-09-30-$41.08M
2013-06-30-$38.95M

Annual Operating Income

DateOperating Income
2025-12-31-$3.6M
2024-12-31-$46.95M
2023-12-31-$56.04M
2022-12-31-$91.96M
2021-12-31-$257.78M
2020-12-31-$297.63M
2019-12-31-$251.92M
2018-12-31-$238.75M
2017-12-31-$260.12M
2016-12-31-$180.47M
2015-12-31-$181.9M
2014-12-31-$232.54M
2013-12-31-$156.28M
2012-12-31-$9.58M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.